These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin. Barry PW Anaesth Intensive Care; 1999 Dec; 27(6):670-1. PubMed ID: 10631434 [No Abstract] [Full Text] [Related]
16. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Walmrath D; Schermuly R; Pilch J; Grimminger F; Seeger W Eur Respir J; 1997 May; 10(5):1084-92. PubMed ID: 9163651 [TBL] [Abstract][Full Text] [Related]
17. Re: Delivery of inhaled aerosolized prostacyclin (IAP). van Heerden PV; Power BM; Leonard RC Anaesth Intensive Care; 1996 Oct; 24(5):624-5. PubMed ID: 8909691 [No Abstract] [Full Text] [Related]
18. Aerosolized iloprost as a bridge to lung transplantation in a patient with cystic fibrosis and pulmonary hypertension. Tissières P; Nicod L; Barazzone-Argiroffo C; Rimensberger PC; Beghetti M Ann Thorac Surg; 2004 Sep; 78(3):e48-50. PubMed ID: 15337084 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. Hoeper MM; Olschewski H; Ghofrani HA; Wilkens H; Winkler J; Borst MM; Niedermeyer J; Fabel H; Seeger W J Am Coll Cardiol; 2000 Jan; 35(1):176-82. PubMed ID: 10636277 [TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Putensen C; Hörmann C; Kleinsasser A; Putensen-Himmer G Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]